[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Elena Elimova<\/i><\/u><\/presenter>. UHN Princess Margaret Cancer Center, Toronto, ON, Canada","CSlideId":"","ControlKey":"e5f3fd55-36a2-46aa-ad1f-2131e59234e0","ControlNumber":"9201","DisclosureBlock":"&nbsp;<b>&nbsp;E. Elimova:<\/b>  ; Adaptimmune LLC. ; Amgen. ; Astellas Pharma. ; AstraZeneca. ; BeiGene, Ltd.. ; Bristol-Myers Squibb. ; Merck. ; Novartis. ; Viracta Tx. ; Zymeworks.","End":"4\/8\/2024 2:31:00 PM","HasWebcast":null,"Highlights":[],"Id":"596","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Elena Elimova, MD","PresenterKey":"daa07ec4-cfce-4d96-92d2-3294dfca6919","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Cochair","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  2:30PM","SessionId":"24","SessionOnDemand":"False","SessionTitle":"AACR-JCA Joint Session: Novel Molecular Drivers of Gastroesophageal Cancers and Evolving Biomarker Driven Therapies","ShowChatLink":"false","Start":"4\/8\/2024 2:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Cochair","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Tatsuhiro Shibata<\/i><\/u><\/presenter>. University of Tokyo, Tokyo, Japan","CSlideId":"","ControlKey":"f24e0000-1140-4498-b32c-803d2305c2a6","ControlNumber":"236","DisclosureBlock":"&nbsp;<b>T. Shibata:<\/b> None.","End":"4\/8\/2024 2:31:00 PM","HasWebcast":null,"Highlights":[],"Id":"73","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Tatsuhiro Shibata, MD;PhD","PresenterKey":"1937eaf7-c87f-4053-ad50-6b0827961192","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Cochair","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  2:30PM","SessionId":"24","SessionOnDemand":"False","SessionTitle":"AACR-JCA Joint Session: Novel Molecular Drivers of Gastroesophageal Cancers and Evolving Biomarker Driven Therapies","ShowChatLink":"false","Start":"4\/8\/2024 2:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Cochair","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Elena Elimova<\/i><\/u><\/presenter>. UHN Princess Margaret Cancer Center, Toronto, ON, Canada","CSlideId":"","ControlKey":"11967d71-b6fe-418e-8dce-0b1d0da43ecc","ControlNumber":"9202","DisclosureBlock":"<b>&nbsp;E. Elimova, <\/b> <br><b>Adaptimmune LLC<\/b> I. <br><b>Amgen<\/b> I. <br><b>Astellas Pharma<\/b> I. <br><b>AstraZeneca<\/b> I. <br><b>BeiGene, Ltd.<\/b> I. <br><b>Bristol-Myers Squibb<\/b> I. <br><b>Merck<\/b> E. <br><b>Novartis<\/b> I. <br><b>Viracta Tx<\/b> I. <br><b>Zymeworks<\/b> I.","End":"4\/8\/2024 2:34:00 PM","HasWebcast":null,"Highlights":[],"Id":"597","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Elena Elimova, MD","PresenterKey":"daa07ec4-cfce-4d96-92d2-3294dfca6919","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Introduction","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  2:30PM","SessionId":"24","SessionOnDemand":"False","SessionTitle":"AACR-JCA Joint Session: Novel Molecular Drivers of Gastroesophageal Cancers and Evolving Biomarker Driven Therapies","ShowChatLink":"false","Start":"4\/8\/2024 2:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Tatsuhiro Shibata<\/i><\/u><\/presenter>. University of Tokyo, Tokyo, Japan","CSlideId":"","ControlKey":"1ea0a181-1175-4bf3-943b-331f033a9303","ControlNumber":"238","DisclosureBlock":"&nbsp;<b>T. Shibata, <\/b> None.","End":"4\/8\/2024 2:57:00 PM","HasWebcast":null,"Highlights":[],"Id":"75","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Tatsuhiro Shibata, MD;PhD","PresenterKey":"1937eaf7-c87f-4053-ad50-6b0827961192","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Molecular genetic analysis of gastric cancer","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  2:30PM","SessionId":"24","SessionOnDemand":"False","SessionTitle":"AACR-JCA Joint Session: Novel Molecular Drivers of Gastroesophageal Cancers and Evolving Biomarker Driven Therapies","ShowChatLink":"false","Start":"4\/8\/2024 2:34:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Molecular genetic analysis of gastric cancer","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":". ","CSlideId":"","ControlKey":"7a4b9072-2cfc-4b35-8225-ed1686d36ff9","ControlNumber":"240","DisclosureBlock":"","End":"4\/8\/2024 3:02:00 PM","HasWebcast":null,"Highlights":[],"Id":"77","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  2:30PM","SessionId":"24","SessionOnDemand":"False","SessionTitle":"AACR-JCA Joint Session: Novel Molecular Drivers of Gastroesophageal Cancers and Evolving Biomarker Driven Therapies","ShowChatLink":"false","Start":"4\/8\/2024 2:57:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Yelena Yuriy Janjigian<\/i><\/u><\/presenter>. Memorial Sloan Kettering Cancer Center, New York, NY","CSlideId":"","ControlKey":"a1e07e00-8f35-4f33-a043-a8b37c9e70c2","ControlNumber":"9206","DisclosureBlock":"<b>&nbsp;Y. Y. Janjigian, <\/b> <br><b>AbbVie<\/b> I. <br><b>AmerisourceBergen Drug Corporation<\/b> I. <br><b>Arcus Biosciences<\/b> I, G. <br><b>Ask-Gene Pharma, Inc.<\/b> I. <br><b>Astellas Pharma<\/b> I. <br><b>AstraZeneca<\/b> I, G. <br><b>Basilea Pharmaceutica Ltd.<\/b> I. <br><b>Bayer<\/b> I, G. <br><b>Bristol-Myers Squibb<\/b> I, G, T. <br><b>Clinical Care Options<\/b> I. <br><b>Cycle for Survival<\/b> G. <br><b>Daiichi Sankyo Company<\/b> I. <br><b>Eli Lilly and Company<\/b> I, G. <br><b>Fred's Team<\/b> G. <br><b>Genentech<\/b> G. <br><b>Geneos Therapeutics<\/b> I. <br><b>GlaxoSmithKline<\/b> I. <br><b>Guardant Health, Inc<\/b> I. <br><b>HMP Education<\/b> I. <br><b>Imedex<\/b> I. <br><b>Imugene<\/b> I. <br><b>Inspirna<\/b> I, S, G. <br><b>Lynx Health<\/b> I. <br><b>Merck<\/b> I, G, T. <br><b>Merck Serono<\/b> I. <br><b>Mersana Therapeutics<\/b> I. <br><b>Michael J. Hennessy Associates<\/b> I. <br><b>National Cancer Institute<\/b> G. <br><b>Paradigm Medical Communications<\/b> I. <br><b>PeerView Institute<\/b> I. <br><b>Pfizer<\/b> I. <br><b>Research to Practice<\/b> I. <br><b>Seagen Inc.<\/b> I. <br><b>Silverback Therapeutics<\/b> I. <br><b>Transcenta<\/b> I, G. <br><b>U.S. Department of Defense<\/b> G. <br><b>Zymeworks, Inc.<\/b> I.","End":"4\/8\/2024 3:25:00 PM","HasWebcast":null,"Highlights":[],"Id":"601","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Yelena Janjigian, MD","PresenterKey":"c98b2943-e42e-4628-bb3d-93f629d6e34d","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"ERBB2 addiction in gastroesophageal cancer: Unveiling innovations, navigating challenges, and charting future frontiers","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  2:30PM","SessionId":"24","SessionOnDemand":"False","SessionTitle":"AACR-JCA Joint Session: Novel Molecular Drivers of Gastroesophageal Cancers and Evolving Biomarker Driven Therapies","ShowChatLink":"false","Start":"4\/8\/2024 3:02:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"ERBB2 addiction in gastroesophageal cancer: Unveiling innovations, navigating challenges, and charting future frontiers","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":". ","CSlideId":"","ControlKey":"e2b173a7-7932-4c23-ace0-02f67f725f30","ControlNumber":"241","DisclosureBlock":"","End":"4\/8\/2024 3:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"78","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  2:30PM","SessionId":"24","SessionOnDemand":"False","SessionTitle":"AACR-JCA Joint Session: Novel Molecular Drivers of Gastroesophageal Cancers and Evolving Biomarker Driven Therapies","ShowChatLink":"false","Start":"4\/8\/2024 3:25:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Kohei Shitara<\/i><\/u><\/presenter>. National Cancer Center Hospital East, Chiba, Japan","CSlideId":"","ControlKey":"2731ed82-525f-4952-a80c-3b53b0d9bd57","ControlNumber":"237","DisclosureBlock":"<b>&nbsp;K. Shitara, <\/b> <br><b>Amgen<\/b> I. <br><b>Astellas Pharma<\/b> I. <br><b>AstraZeneca<\/b> I. <br><b>Bayer<\/b> I. <br><b>Boehringer Ingelheim<\/b> I. <br><b>Bristol Myers Squibb Company<\/b> I. <br><b>Bristol-Myers Squibb<\/b> I. <br><b>Chugai Pharmaceutical Co., Ltd.<\/b> I. <br><b>Daiichi Sankyo Inc.<\/b> I. <br><b>Eisai Co., Ltd.<\/b> I. <br><b>Eli LIlly<\/b> I. <br><b>Janssen Pharmaceuticals<\/b> I. <br><b>Merck<\/b> I. <br><b>Novartis<\/b> I. <br><b>Ono Medical Research Foundation<\/b> I. <br><b>Taiho Pharmaceutical<\/b> I. <br><b>Takeda Pharmaceutical Company<\/b> I.","End":"4\/8\/2024 3:53:00 PM","HasWebcast":null,"Highlights":[],"Id":"74","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Kohei Shitara, MD","PresenterKey":"b36f89e0-9e9c-4fbe-a43e-6fd97f9e132f","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Emerging targets for gastro-esophageal cancer: CLDN18.2 and FGFR2","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  2:30PM","SessionId":"24","SessionOnDemand":"False","SessionTitle":"AACR-JCA Joint Session: Novel Molecular Drivers of Gastroesophageal Cancers and Evolving Biomarker Driven Therapies","ShowChatLink":"false","Start":"4\/8\/2024 3:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Emerging targets for gastro-esophageal cancer: CLDN18.2 and FGFR2","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":". ","CSlideId":"","ControlKey":"bd01ca62-4e1b-4e94-b0e4-db9f08c24f78","ControlNumber":"9208","DisclosureBlock":"","End":"4\/8\/2024 3:58:00 PM","HasWebcast":null,"Highlights":[],"Id":"603","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"9","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  2:30PM","SessionId":"24","SessionOnDemand":"False","SessionTitle":"AACR-JCA Joint Session: Novel Molecular Drivers of Gastroesophageal Cancers and Evolving Biomarker Driven Therapies","ShowChatLink":"false","Start":"4\/8\/2024 3:53:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Elena Elimova<\/i><\/u><\/presenter>. UHN Princess Margaret Cancer Center, Toronto, ON, Canada","CSlideId":"","ControlKey":"7401bfe6-7a15-4a4f-b300-c77d3735fd72","ControlNumber":"9205","DisclosureBlock":"<b>&nbsp;E. Elimova, <\/b> <br><b>Adaptimmune LLC<\/b> I. <br><b>Amgen<\/b> I. <br><b>Astellas Pharma<\/b> I. <br><b>AstraZeneca<\/b> I. <br><b>BeiGene, Ltd.<\/b> I. <br><b>Bristol-Myers Squibb<\/b> I. <br><b>Merck<\/b> E. <br><b>Novartis<\/b> I. <br><b>Viracta Tx<\/b> I. <br><b>Zymeworks<\/b> I.","End":"4\/8\/2024 4:21:00 PM","HasWebcast":null,"Highlights":[],"Id":"600","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"10","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Elena Elimova, MD","PresenterKey":"daa07ec4-cfce-4d96-92d2-3294dfca6919","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"The role of immunotherapy in the management of gastroesophageal cancers and biomarkers that predict response","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  2:30PM","SessionId":"24","SessionOnDemand":"False","SessionTitle":"AACR-JCA Joint Session: Novel Molecular Drivers of Gastroesophageal Cancers and Evolving Biomarker Driven Therapies","ShowChatLink":"false","Start":"4\/8\/2024 3:58:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"The role of immunotherapy in the management of gastroesophageal cancers and biomarkers that predict response","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":". ","CSlideId":"","ControlKey":"25d61ce0-9799-4e32-b1d9-e8e18aca5e7b","ControlNumber":"9207","DisclosureBlock":"","End":"4\/8\/2024 4:26:00 PM","HasWebcast":null,"Highlights":[],"Id":"602","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"11","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  2:30PM","SessionId":"24","SessionOnDemand":"False","SessionTitle":"AACR-JCA Joint Session: Novel Molecular Drivers of Gastroesophageal Cancers and Evolving Biomarker Driven Therapies","ShowChatLink":"false","Start":"4\/8\/2024 4:21:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>Tatsuhiro Shibata<\/i><\/u><\/presenter>. University of Tokyo, Tokyo, Japan","CSlideId":"","ControlKey":"a3d2f105-89e4-46e2-aca2-d837262e7213","ControlNumber":"239","DisclosureBlock":"&nbsp;<b>T. Shibata, <\/b> None.","End":"4\/8\/2024 4:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"76","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"12","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Tatsuhiro Shibata, MD;PhD","PresenterKey":"1937eaf7-c87f-4053-ad50-6b0827961192","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Closing Remarks","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  2:30PM","SessionId":"24","SessionOnDemand":"False","SessionTitle":"AACR-JCA Joint Session: Novel Molecular Drivers of Gastroesophageal Cancers and Evolving Biomarker Driven Therapies","ShowChatLink":"false","Start":"4\/8\/2024 4:26:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Closing Remarks","Topics":null,"cSlideId":""}]